Status:
COMPLETED
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children
Lead Sponsor:
Pfizer
Conditions:
Neutropenia
Eligibility:
All Genders
2-12 years
Phase:
PHASE1
PHASE2
Brief Summary
This is a study to investigate the pharmacokinetics, safety and tolerability of several doses of voriconazole, intravenous and oral suspension formulations, in children
Eligibility Criteria
Inclusion
- Children who require a systemic antifungal agent for the prevention of systemic fungal infection
Exclusion
- Children who are receiving medications which cannot be taken concomitantly with voriconazole.
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00174473
Start Date
June 1 2003
End Date
August 1 2005
Last Update
May 10 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.